63/100BCiena stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Ciena is 507.42, 85.4% above the current price of 273.74. Their targets range from 347.00 to 615.00.
Of the 15 firms that rated Ciena in the past 12 months, 12 rate it buy or strong buy, 3 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 347.00 to 615.00, with an average of 507.42.
| Buy | 12 | |
| Hold | 3 | |
| Sell | 0 |
12-month price target
| Highest target | 615.00 |
| Average target | 507.42 |
| Lowest target | 347.00 |
| Current price | 273.74 |
Ciena price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Ciena price target and rating?
How analysts rate Ciena, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
12 of 15 firms rate it buy now, against 9 of 13 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Ciena analyst upgrades, downgrades and price targets
The latest rating change came on 21 September 2026, when Evercore ISI upgraded Ciena from In Line to Outperform. Its price target is 550.00, from 375.00. The most recent new target came from Bernstein on 30 September 2026: 440.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 30 Sept 2026 | Bernstein Daniel Zhu | — | 440.00 | — | 354.92 |
| 21 Sept 2026 | Evercore ISI | Upgraded · In Line → Outperform | 375.00 → 550.00 | +46.7% | 348.80 |
| 17 Sept 2026 | Barclays Tim Long | Reiterated · Overweight | 475.00 → 548.00 | +15.4% | 355.23 |
| 17 Sept 2026 | Northland Securities | — | 500.00 → 550.00 | +10.0% | 362.33 |
| 17 Sept 2026 | Morgan Stanley Meta Marshall | Reiterated · Equal Weight | 425.00 → 450.00 | +5.9% | 340.50 |
| 10 Sept 2026 | Argus Research | — | 650.00 → 550.00 | -15.4% | 344.08 |
| 4 Sept 2026 | UBS David Vogt | Reiterated · Neutral | 508.00 → 394.00 | -22.4% | 320.33 |
| 4 Sept 2026 | Morgan Stanley | Reiterated · Equal Weight | 490.00 → 425.00 | -13.3% | 322.16 |
| 4 Sept 2026 | Barclays Tim Long | Reiterated · Overweight | 607.00 → 475.00 | -21.7% | 317.46 |
| 4 Sept 2026 | C.L. King Dave King | — | 347.00 | — | 317.46 |
| 4 Sept 2026 | Rosenblatt Securities Mike Genovese | Reiterated · Buy | 350.00 → 525.00 | +50.0% | 317.46 |
| 3 Sept 2026 | Evercore ISI | — | 330.00 → 375.00 | +13.6% | 317.46 |
| 3 Sept 2026 | Needham | Reiterated · Buy | 600.00 → 520.00 | -13.3% | 317.46 |
| 3 Sept 2026 | Raymond James Simon Leopold | — | 530.00 → 600.00 | +13.2% | 315.63 |
| 19 Aug 2026 | Northland Securities | Upgraded · Market Perform → Outperform | 450.00 → 500.00 | +11.1% | 405.54 |
| 5 Jun 2026 | Argus Research Jim Kelleher | — | 370.00 → 650.00 | +75.7% | 521.20 |
| 5 Jun 2026 | Northland Securities Tim Savageaux | — | 190.00 → 450.00 | +136.8% | 503.77 |
| 5 Jun 2026 | Barclays | Reiterated · Overweight | 279.00 → 607.00 | +117.6% | 535.63 |
| 5 Jun 2026 | Morgan Stanley Meta Marshall | Reiterated · Equal Weight | 405.00 → 490.00 | +21.0% | 535.63 |
| 5 Jun 2026 | UBS David Vogt | Reiterated · Neutral | 285.00 → 508.00 | +78.2% | 535.63 |
| 4 Jun 2026 | Needham Ryan Koontz | — | 370.00 → 600.00 | +62.2% | 535.63 |
| 4 Jun 2026 | Raymond James | Reiterated · Outperform | 320.00 → 530.00 | +65.6% | 528.97 |
| 29 May 2026 | Stifel Nicolaus Ruben Roy | — | 585.00 → 615.00 | +5.1% | 570.18 |
| 5 May 2026 | Stifel Nicolaus Ruben Roy | Reiterated · Buy | 320.00 → 585.00 | +82.8% | 538.51 |
| 1 May 2026 | Redburn Partners Mike Harrison | — | 416.00 | — | 527.58 |
| 20 Apr 2026 | Morgan Stanley | Reiterated · Equal Weight | 286.00 → 405.00 | +41.6% | 506.57 |
| 9 Mar 2026 | Argus Research | — | 280.00 → 370.00 | +32.1% | 318.54 |
| 6 Mar 2026 | UBS David Vogt | Reiterated · Neutral | 230.00 → 285.00 | +23.9% | 305.42 |
| 6 Mar 2026 | Rosenblatt Securities Mike Genovese | Reiterated · Buy | 350.00 | — | 304.24 |
| 6 Mar 2026 | B of A Securities | Upgraded · Neutral → Buy | — | — | — |
| 5 Mar 2026 | Morgan Stanley Meta Marshall | — | 280.00 → 286.00 | +2.1% | 299.30 |
| 5 Mar 2026 | Wolfe Research George Notter | — | 375.00 | — | 299.30 |
| 5 Mar 2026 | Stifel Nicolaus Ruben Roy | — | 280.00 → 320.00 | +14.3% | 299.30 |
| 5 Mar 2026 | Raymond James Simon Leopold | — | 240.00 → 320.00 | +33.3% | 299.35 |
| 5 Mar 2026 | Needham Ryan Koontz | Reiterated · Buy | 240.00 → 370.00 | +54.2% | 296.45 |
| 23 Feb 2026 | Morgan Stanley | Reiterated · Equal Weight | 213.00 → 280.00 | +31.5% | 334.95 |
| 19 Feb 2026 | Evercore ISI | Reiterated · In Line | 240.00 → 330.00 | +37.5% | 308.13 |
| 22 Jan 2026 | Stifel Nicolaus | Reiterated · Buy | 270.00 → 280.00 | +3.7% | 228.39 |
| 20 Jan 2026 | B of A Securities | Downgraded · Buy → Neutral | — | — | — |
| 17 Dec 2025 | Morgan Stanley | Reiterated · Equal Weight | 195.00 → 213.00 | +9.2% | 209.84 |
| 12 Dec 2025 | Argus Research | Reiterated · Buy | 280.00 | — | 220.46 |
| 12 Dec 2025 | UBS David Vogt | Reiterated · Neutral | 120.00 → 230.00 | +91.7% | 225.65 |
| 12 Dec 2025 | Morgan Stanley Meta Marshall | Reiterated · Equal Weight | 185.00 → 195.00 | +5.4% | 225.19 |
| 12 Dec 2025 | Northland Securities Tim Savageaux | — | 100.00 → 190.00 | +90.0% | 242.25 |
| 12 Dec 2025 | Barclays | Reiterated · Overweight | 100.00 → 279.00 | +179.0% | 242.25 |
| 11 Dec 2025 | Raymond James | — | 250.00 → 240.00 | -4.0% | 242.25 |
| 11 Dec 2025 | Stifel Nicolaus Ruben Roy | — | 230.00 → 270.00 | +17.4% | 242.25 |
| 11 Dec 2025 | Evercore ISI | — | 240.00 | — | 240.19 |
| 11 Dec 2025 | Raymond James | — | 250.00 | — | 240.16 |
| 9 Dec 2025 | Stifel Nicolaus | Reiterated · Buy | 230.00 | — | 212.93 |
Ciena EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Ciena's EPS to grow 174.2% a year until 2028. Over the last 5 years it fell 18.2% a year, and over the last 3 years it fell 5.3%.
Analysts expect Ciena's revenue to grow 31.9% a year until 2028, faster than over the last 5 years (6.2% a year) and the last 3 years (9.5%).
Revenue
EPS
Does Ciena beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 28.8% off the result, either way, and their revenue estimate 2.5%, over the last 12 quarters.
- EPS beats
- 89 / 118
- Revenue beats
- 80 / 118
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +22.6%
- Since
- May 1997
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 3 Sept 2026 | 1.73 | 2.11 | +22.0% | 1.64B | 1.67B | +2.1% |
| Q2 FY2026 | 4 Jun 2026 | 1.46 | 1.64 | +12.3% | 1.50B | 1.57B | +4.4% |
| Q1 FY2026 | 5 Mar 2026 | 1.17 | 1.35 | +15.4% | 1.40B | 1.43B | +2.0% |
| Q4 FY2025 | 11 Dec 2025 | 0.78 | 0.91 | +16.7% | 1.29B | 1.35B | +4.7% |
| Q3 FY2025 | 4 Sept 2025 | 0.53 | 0.67 | +26.4% | 1.17B | 1.22B | +3.8% |
| Q2 FY2025 | 5 Jun 2025 | 0.52 | 0.42 | -18.9% | 1.09B | 1.13B | +3.0% |
| Q1 FY2025 | 11 Mar 2025 | 0.41 | 0.64 | +54.7% | 1.05B | 1.07B | +1.9% |
| Q4 FY2024 | 12 Dec 2024 | 0.66 | 0.54 | -18.2% | 1.10B | 1.12B | +1.9% |
| Q3 FY2024 | 4 Sept 2024 | 0.26 | 0.35 | +34.6% | 930.45M | 942.31M | +1.3% |
| Q2 FY2024 | 6 Jun 2024 | 0.15 | 0.27 | +80.0% | 897.16M | 910.83M | +1.5% |
| Q1 FY2024 | 7 Mar 2024 | 0.48 | 0.66 | +37.5% | 1.02B | 1.04B | +1.7% |
| Q4 FY2023 | 7 Dec 2023 | 0.69 | 0.75 | +8.7% | 1.10B | 1.13B | +2.2% |
Ciena stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Ciena's earnings grow at the 88.0% a year analysts expect to FY2028, then 15.0% a year, it would earn about 23.18 a share in FY2030. At the P/E it has traded at over the last five years (16.9 to 59.3) that is 390.86 to 1,373.59 a share, or 857.01 at its average P/E of 37.0. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 7.17 | 120.81 | 264.89 | 424.56 |
| FY2027 | 11.85 | 199.77 | 438.02 | 702.04 |
| FY2028 | 17.53 | 295.55 | 648.02 | 1,038.63 |
| FY2029 (extrapolated) | 20.16 | 339.88 | 745.23 | 1,194.42 |
| FY2030 (extrapolated) | 23.18 | 390.86 | 857.01 | 1,373.59 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 15.0% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (16.9, 37.0, 59.3).
Is Ciena stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Ciena's P/E of 59.3 is above the middle of its 5-year range (15.2 to 410.2, median 34.9). Analysts expect faster growth than in recent years, which can explain part of the high P/E. Fair value is not a reliable guide for Ciena: its earnings swing (EPS fell 66.1% in FY2024), so its usual P/E would mislead. Its forward P/E, on the consensus for FY2027, is 23.1.
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 59.25
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 34.91
- Five-year P/E range
- 15.2 – 410.2
- Forward P/E (FY2027)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 23.10
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 0.67
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +85.4%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 235.690 | 464.49205Price 235.69627 | +97.1% | |
| 28.860 | 56.2634Price 28.8696 | +94.9% | |
| 199.110 | 384.58163Price 199.112,644 | +93.1% | |
| 123.990 | 237.24178Price 123.99297 | +91.3% | |
| 157.820 | 297.58169Price 157.82471 | +88.6% | |
| 162.670 | 305.52160Price 162.67396 | +87.8% | |
| 216.610 | 405.38304Price 216.61507 | +87.1% |
Furthest below the fair value on each stock's page, updated every day.